Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

40,426 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Trajectories of postoperative hepatitis B virus (HBV) DNA and HBV-related hepatocellular carcinoma outcomes.
Xiang YJ, Wang K, Qin YY, Liu ZH, Yu HM, Cheng YQ, Gu HY, Feng JK, Ni QZ, Zhu HF, Yang SY, Lin EH, Cai WT, Cheng DH, Tang YF, Zhang F, Liang C, Zhou HK, Wu W, Li JJ, Shan YF, Cheng SQ. Xiang YJ, et al. Among authors: wang k. Eur J Surg Oncol. 2024 Nov 23;51(2):109492. doi: 10.1016/j.ejso.2024.109492. Online ahead of print. Eur J Surg Oncol. 2024. PMID: 39615296
Association of type 2 diabetes mellitus with incidences of microvascular invasion and survival outcomes in hepatitis B virus-related hepatocellular carcinoma after liver resection: A multicenter study.
Zhang XP, Chai ZT, Feng JK, Zhu HM, Zhang F, Hu YR, Zhong CQ, Chen ZH, Wang K, Shi J, Guo WX, Chen CS, Wu MC, Lau WY, Cheng SQ. Zhang XP, et al. Among authors: wang k. Eur J Surg Oncol. 2022 Jan;48(1):142-149. doi: 10.1016/j.ejso.2021.08.010. Epub 2021 Aug 13. Eur J Surg Oncol. 2022. PMID: 34452770
A novel classification in predicting prognosis and guiding postoperative management after R0 liver resection for patients with hepatocellular carcinoma and microvascular invasion.
Wang K, Xiang YJ, Yu HM, Cheng YQ, Qin YY, Wang WJ, Zhang XP, Zheng YT, Shan YF, Cong WM, Dong H, Lau WY, Cheng SQ. Wang K, et al. Among authors: wang wj. Eur J Surg Oncol. 2022 Jun;48(6):1348-1355. doi: 10.1016/j.ejso.2021.12.466. Epub 2021 Dec 29. Eur J Surg Oncol. 2022. PMID: 34996665
Transarterial chemoembolization plus immune checkpoint inhibitor as postoperative adjuvant therapy for hepatocellular carcinoma with portal vein tumor thrombus: A multicenter cohort study.
Yuan L, Feng J, Zhang Y, Lu C, Xu L, Liang C, Liu Z, Mao F, Xiang Y, Wang W, Wang K, Cheng S. Yuan L, et al. Among authors: wang w, wang k. Eur J Surg Oncol. 2023 Jul;49(7):1226-1233. doi: 10.1016/j.ejso.2023.01.020. Epub 2023 Jan 18. Eur J Surg Oncol. 2023. PMID: 36739252
Association of Preoperative Hypercoagulability with Poor Prognosis in Hepatocellular Carcinoma Patients with Microvascular Invasion After Liver Resection: A Multicenter Study.
Zhang XP, Zhou TF, Wang ZH, Zhang F, Zhong CQ, Hu YR, Wang K, Chai ZT, Chen ZH, Wu MC, Lau WY, Cheng SQ. Zhang XP, et al. Among authors: wang zh, wang k. Ann Surg Oncol. 2019 Nov;26(12):4117-4125. doi: 10.1245/s10434-019-07504-7. Epub 2019 Jul 18. Ann Surg Oncol. 2019. PMID: 31321582
40,426 results
You have reached the last available page of results. Please see the User Guide for more information.